West Pharmaceutical Services Boosts Liquidity with $5.36% Class A Notes for 2026
West Pharmaceutical Services boosts liquidity with new Class A notes, pairing low‑cost debt to fund automation, supply‑chain resilience and higher margins in Australia’s value‑based healthcare market.
- WEST PHARMACEUTICAL SERVICES
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read








